Altimmune ALT Short-Term Investments
Short-Term Investments at other companies
Other financials
Where this comes from
Reported directly by Altimmune in its filing.
Tagged under the XBRL concept us-gaap:ShortTermInvestments.
The official record: Altimmune’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Altimmune's short-term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Altimmune's short-term investments?
- Altimmune (ALT) reported short-term investments of $233.94M in Q1 2026.
- How has Altimmune's short-term investments changed year-over-year?
- Altimmune's short-term investments increased by 132.3% year-over-year, from $100.72M to $233.94M.
- What is the long-term trend for Altimmune's short-term investments?
- Over 4 years (2020 to 2025), Altimmune's short-term investments has grown at a 23.1% compound annual growth rate (CAGR), from $100.01M to $229.7M.
- What does short-term investments mean?
- Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.